Introduction {#s1}
============

The vertebrate nervous system is highly evolved to extract, integrate, retrieve, and transform information, a functional sophistication that is mirrored in the complexity of its underlying neural circuits. These circuits are produced by precisely orchestrated patterns of neuronal proliferation, migration, and differentiation, and by the establishment of specific synaptic connections between neurons and their targets. For neurons with distant targets, making the appropriate connections depends on accurate long-range navigation by their growing axons ([@bib17]; [@bib50]).

Motor neurons represent an attractive system in which to study axonal growth and guidance because motor axons generally grow over great distances along highly stereotyped pathways. Motor neurons in the brainstem extend their axons within cranial nerves to control muscles involved in feeding, facial expression, and eye, neck, and head movements ([@bib25]). Motor neurons in the spinal cord are arranged in longitudinal columns along the rostrocaudal axis, and the neurons in different columns innervate distinct peripheral targets ([@bib39]; [@bib10]). Spinal motor neurons in the lateral motor column (LMC) innervate the limbs and are therefore present only at brachial and lumbar levels. The LMC is divided into lateral (LMC~L~) and medial (LMC~M~) divisions, which innervate, respectively, the dorsal and ventral limb musculature.

For motor axons that innervate the limb musculature, different signaling systems---including the Cxcl12/Cxcr4, GDNF/Ret, Ephrin/Eph, and Semaphorin/Neuropilin (Npn) systems---provide information at different decision points during axonal navigation ([@bib26]; [@bib30]; [@bib40]; [@bib38]; [@bib41]; [@bib9]; reviewed in [@bib10]). Cxcl12/Cxcr4 signaling is required for the initial emergence of motor axons from the ventral face of the spinal cord, with ventral axons expressing the Cxcr4 receptor and thereby conferring responsiveness to Cxcl12, which is produced by the adjacent mesenchyme. Sema3A, which is produced throughout the limb bud mesenchyme, acts on Npn1-expressing motor axons shortly after these axons emerge from the spinal cord to control the timing of outgrowth and axon fasciculation; and Sema3F, which is produced in the dorsal limb mesenchyme, repels Npn2-expressing LMC~M~ axons to promote a ventral trajectory. The dorsal/ventral decision is also controlled by cooperative and mutually reinforcing interactions between Ephrin/Eph and GDNF/Ret signaling. GDNF, which is produced in the dorsal limb bud, attracts LMC~L~ axons, which express high levels of the Ret receptor. Ephrin-A, which is produced in the ventral limb bud, repels LMC~L~ axons, which express EphA4. At present, the signaling pathways that determine more distal axon branching patterns and control the specificity of nerve-muscle recognition remain largely unknown.

The experiments described here reveal an important role for Frizzled signaling in motor axon growth. Frizzled receptors are found throughout the animal kingdom and mediate at least three distinct types of signaling: (1) canonical signaling, in which Wnt binding to Frizzled activates an Lrp co-receptor to elicit stabilization of cytosolic beta-catenin, which then migrates to the nucleus to control gene expression in cooperation with LEF/TCF transcription factors; (2) tissue polarity or planar cell polarity (PCP) signaling, which acts in many epithelia and features the asymmetric localization of Frizzled and several other proteins in plasma membrane complexes to control cytoskeletal organization; and (3) Wnt/calcium signaling, the least understood of the three pathways, in which Wnt binding to Frizzled receptors leads to release of intracellular calcium ([@bib1]; [@bib49]). The PCP pathway was discovered in *Drosophila* as a regulator of cuticular hair and bristle polarity ([@bib64]). The core set of PCP proteins defined by the *Drosophila* experiments---Frizzled, Dishevelled, Van Gogh/Strabismus, Prickle, Flamingo/Starry Night, and Diego---are conserved in vertebrates. Over the past 15 years, studies in mice, frogs, and zebrafish have shown that core PCP genes play central roles in a wide variety of developmental processes that involve directional information: coordinating cell movements during neural tube elongation and closure (convergent/extension movements), setting up the global orientation of hairs within mammalian skin, orienting motile cilia within epithelia to produce coherent fluid flow, and orienting asymmetric bundles of stereocilia on the apical faces of auditory and vestibular sensory hair cells ([@bib69]; [@bib6]; [@bib22]).

In mammals, two of the ten Frizzled family members---Frizzled3 (Fz3) and Fz6---appear to be devoted largely or exclusively to tissue polarity signaling. Fz6 controls hair orientation, and Fz3 and Fz6 act redundantly to control inner ear sensory hair cell orientation and neural tube closure ([@bib24]; [@bib73]). Among Frizzled receptors, Fz3 is unique in its role in controlling axon guidance in the central nervous system (CNS), where it is required for the development of major fiber tracts, including the corpus callosum, and the thalamocortical, corticothalamic, and nigrostriatal tracts ([@bib72], [@bib74]). Fz3 appears to be part of a system that provides directional information to growing axons, as indicated by the observation that in *Fz3*^*−/−*^ embryos commissural sensory axons in the spinal cord orient randomly instead of turning rostrally after midline crossing ([@bib42]). Virtually identical CNS axon phenotypes are observed in embryos lacking Celsr3, one of three mammalian homologues of the core PCP protein Flamingo/Starry Night ([@bib68]). Fz3 and Celsr1-Celsr3 are also required for caudal and tangential migration of VII^th^ cranial (facial branchiomotor) nerve neurons within the developing brainstem ([@bib55]). In the periphery, Fz3 and Celsr3 are required for correctly orienting enteric neurons within the gastrointestinal tract, and Fz3 is required for the development of sympathetic chain ganglia and innervation of sympathetic targets ([@bib3]; [@bib58]).

In the present work, we have identified a hitherto unrecognized role for Fz3 in the growth of motor axons. Using conventional and conditional loss-of-function alleles for *Fz3*, we show that *Fz3* is required for a subset of cranial and spinal motor axons to grow to their peripheral targets. In the limb, the absence of *Fz3* leads to a specific stalling defect among LMC~L~ axons that is distinct from the phenotypes produced by defects in several other signaling systems active in limb axon guidance. Affected cranial and spinal motor neurons die shortly after their axons stall, providing in vivo evidence for the general idea that as growing axons arrive at intermediate targets essential survival signals are relayed to their cell bodies.

Results {#s2}
=======

A survey of peripheral nerve defects in *Fz3*^*−/−*^ embryos {#s2-1}
------------------------------------------------------------

*Fz3* is widely expressed in the developing mouse CNS, and therefore it seemed possible that its loss might impair neurodevelopmental processes other than those previously described in the forebrain ([@bib72], [@bib74]). To systematically assess peripheral axon growth and guidance in E11.5-E13.5 embryos, we visualized Neurofilament-M (hereafter 'NF') immunoreactivity in whole-mount tissues and in thick (0.7--1 mm) vibratome sections. We also used the *Hb9-EGFP* transgene to visualize spinal motor axons, including the phrenic nerve, and the motor component of a subset of cranial nerves ([@bib76]; [@bib31]).

In E11.5-E13.5 *Fz3*^*−/−*^ embryos anti-NF immunostaining revealed a thinning of the XII^th^ (hypoglossal) nerve ([Figure 1B,B′](#fig1){ref-type="fig"}), the phrenic nerve ([Figure 1C,C′](#fig1){ref-type="fig"}), and the dorsal nerves of the fore- and hindlimbs (described more fully below). Flatmounts of E18.5 *Hb9-EGFP;Fz3*^*−/−*^ diaphragms co-stained for GFP and nicotinic acetylcholine receptors (using alpha-bungarotoxin; 'alpha-BTX') showed variability in phrenic nerve thickness within the diaphragm that correlated with nerve branching defects, and a decrease in the number of neuromuscular junctions ([Figure 1D--H′′](#fig1){ref-type="fig"}). The innervation defect was especially common in the most ventral region of the diaphragm where many alpha-BTX binding sites were scattered across the muscle surface, both diffusely and in clusters, indicative of a failure of neuromuscular junction formation.10.7554/eLife.01482.003Figure 1.Defects in the XII^th^ cranial (hypoglossal) and phrenic nerves in *Fz3^−/−^* embryos.(**A**--**C′**) Anti-NF immunostaining shows thinned XII^th^ and phrenic nerves (green arrows in \[**B**\] and \[**C**\] vs red arrowheads in \[**B′**\] and \[**C′**\]) in E11.5 *Fz3*^*−/−*^ embryos. The nerve roots and the proximal segment of the XII^th^ nerve appear to be unaffected. Enlarged views of the phrenic and XII^th^ nerves in (**B**--**C′**) are maximum intensity projections from consecutive Z stacks. Scale bars: (**A′**), 1 mm; (**B′**) and (**C′**), 200 *µ*m. (**D**--**H′′**) Flatmounts of the diaphragm show variably defective motor innervation in E18.5 *Hb9-EGFP;Fz3*^*−/−*^ embryos. Panels (**D**--**H**) show half of a diaphragm with the midline at the top. (**D′**--**H′**) and (**D′′**--**H′′**) show enlargements of the lateral and ventral regions, respectively, boxed in (**D**--**H**). D, dorsal; V, ventral; M, medial; L, lateral. (**E**--**H**) show examples of mild, moderate, severe, and complete phenotypes, with the fraction of embryos in each class shown in parentheses. Scale bars: (**H**), 1 mm; (**H**′′), 100 *µ*m.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.003](10.7554/eLife.01482.003)

We have classified phrenic nerve defects as mild (the entire diaphragm innervated, but thin phrenic nerve and a decrease in the number of branches and synapses), moderate (similar to mild defects but, additionally, ventral diaphragm not innervated), severe (similar to moderate defects, and, additionally, the crus of the diaphragm not innervated), and complete (phrenic nerve is very thin with minimal innervation across the diaphragm). Among 23 *Fz3*^*−/−*^ hemi-diaphragms analyzed, the frequencies of these classes were 4/23, 14/23, 4/23, and 1/23, respectively ([Figure 1E--H′′](#fig1){ref-type="fig"}). Among 42 *wildtype* (*WT*) or *Fz3*^*+/−*^ control hemi-diaphragms, all showed complete diaphragm innervation, with alpha-BTX binding sites tightly clustered at nerve terminals ([Figure 1D--D′′](#fig1){ref-type="fig"}).

Diverse defects in cholinergic neurons in *Fz3*^*−/−*^ embryos {#s2-2}
--------------------------------------------------------------

Most peripheral nerves are composed of both motor and sensory axons, and therefore a defect in one of these components would be expected to produce a decrease in nerve thickness but not a complete absence of the nerve when visualized with NF immunostaining. To search selectively for defects in cholinergic neurons, including motor neurons, we examined *Fz3*^*−/−*^ embryos that carried a *ChAT-IRES-Cre* knock-in allele and a Cre-controlled alkaline phosphatase (AP) reporter, *R26iAP* ([@bib4]). In the mouse embryo, *Choline acetyl transferase* (*ChAT*) expression is first detectable at ∼E13.5 ([@bib61]; [@bib33]). However, the rate of accumulation of endogenous ChAT protein is insufficient for robust immunostaining of axons in the prenatal period. By contrast, in *ChAT-IRES-Cre*;*R26iAP* mice, Cre-mediated activation of the *AP* reporter leads to sufficient AP accumulation by E18.5 for histochemical labeling of both cholinergic cell bodies and axons. Since *Fz3*^*−/−*^ mice die as neonates, the high sensitivity of the *ChAT-IRES-Cre*;*R26iAP* method recommended it for surveying late prenatal cholinergic axons.

Cholinergic neurons in the mouse telencephalon can be divided into two major groups: local interneurons in the striatum and projection neurons in the basal forebrain. As seen in [Figure 2B](#fig2){ref-type="fig"}, striatal cholinergic neurons are present in E18.5 *ChAT-IRES-Cre*;*R26iAP*;*Fz3*^*−/−*^ forebrains, but a major cholinergic fiber tract passing through the striatum is missing (compare [Figure 2Bf,Bg](#fig2){ref-type="fig"} vs [Figure 2Bf′,Bg′](#fig2){ref-type="fig"}). In *Fz3*^*−/−*^ brains, cortical and thalamic axons fail to enter the internal capsule and, as a result, the cerebral cortex and the thalamus are disconnected ([@bib72], [@bib74]). The cholinergic fiber tract that is missing in the E18.5 *Fz3*^*−/−*^ forebrain could depend on the same internal capsule navigation system that instructs cortical and thalamic fibers ([@bib79]).10.7554/eLife.01482.004Figure 2.Diverse defects in cholinergic neurons shown by AP histochemisty in *ChAT-IRES-Cre;R26iAP;Fz3^−/−^* embryos.(**A**) Diagram showing the planes of sections from E18.5 heads in (**B**--**I′**). (**B**) Forebrain cholinergic neurons in consecutive coronal sections. The major cholinergic fiber tract passing through the striatum is missing in the *Fz3*^*−/−*^ forebrain \[green arrows in \[**f**\] and \[**g**\] vs red arrowheads in \[**f′**\] and \[**g′**\]\]. GP, globus pallidus. Scale bar, 1 mm. (**C**--**E′**) Innervation of facial muscles by the VII^th^ nerve in sagittal (**C**--**D′**) and coronal (**E** and **E′**) sections. In the *Fz3*^*−/−*^ head, facial muscles are not innervated (green arrows in \[**C**--**E**\] vs red arrows in \[**C′**--**E′**\]). Scale bars, 1 mm. (**F**--**G′**) Innervation of tongue musculature by the XII^th^ nerve in sagittal (**F** and **F′**) and coronal (**G** and **G′**) tongue sections. In *Fz3*^*−/−*^ embryos, the number of axons is reduced (green arrows in \[**F**\] and \[**G**\] vs red arrows in \[**F′**\] and \[**G′**\]). Scale bars, 1 mm. (**H**--**I′**) Cholinergic neurons in the vomeronasal organ in coronal head sections. In *Fz3*^*−/−*^ embryos, these neurons are markedly reduced (green arrows in \[**H**\] and \[**I**\] vs red arrows in \[**H′**\] and \[**I′**\]). Scale bars: (**H′**), 1 mm; (**I′**), 200 *µ*m. (**J**--**M′**) Innervation of the diaphragm by the phrenic nerve visualized by AP histochemistry on flat-mount diaphragms. (**K**--**M**), enlarged views of boxed regions in (**J**); (**K′**--**M′**), enlarged views of boxed regions in (**J′**). Branching is diminished and number of motor terminals is reduced in the moderately affected *Fz3*^*−/−*^ diaphragm ([Figure 1D--H](#fig1){ref-type="fig"}). D, dorsal; V, ventral. Scale bars, 1 mm.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.004](10.7554/eLife.01482.004)10.7554/eLife.01482.005Figure 2---figure supplement 1.Oculomotor (III^rd^), trochlear (IV^th^), and abducens (VI^th^) nerves and their target innervation are not affected by loss of *Fz3*.(**A**--**L′**) III^rd^ and IV^th^ nuclei and nerves visualized by AP staining on continuous coronal sections from E18.5 *ChAT-IRES-Cre;R26iAP;Fz3*^*+/−*^ (**A**--**L**) and *ChAT-IRES-Cre;R26iAP;Fz3*^*−/−*^ (**A′**--**L′**) mouse heads. Motor nuclei and axon tracts or nerves are indicated by arrows and arrowheads, respectively. Panels (**E**/**E′**) here match panels (a/a') of [Figure 2---figure supplement 2G](#fig2s2){ref-type="fig"}. Panels (**F**/**F′**--**K**/**K′**) here match panels (b/b'-g/g') of [Figure 2---figure supplement 2G](#fig2s2){ref-type="fig"}, but are vertically offset as indicated by the red arrows connecting panels (**E**/**E**′) and (**F**/**F′**). The locations of the sections in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} are shown schematically in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, panel (**J**). Scale bar, 1 mm. (**M**--**R′**) Innervation of extraocular muscles by III^rd^, IV^th^, and VI^th^ nerves visualized by AP staining on continuous coronal sections from E18.5 *ChAT-IRES-Cre;R26iAP;Fz3*^*+/−*^ (**M**--**R**) and *ChAT-IRES-Cre;R26iAP;Fz3*^*−/−*^ (**M′**--**R′**) heads. Scale bar, 1 mm. (**S** and **S′**) III^rd^ and IV^th^ nerves visualized in lateral views of NF immunostained whole-mount E11.5 *Fz3*^*+/−*^ (S) and *Fz3*^*−/−*^ (**S′**) embryos, as shown in [Figure 1A,A′](#fig1){ref-type="fig"}. Scale bar, 500 *µ*m. (**T** and **T′**) The VI^th^ nerve visualized by NF and GFP immunostaining on 100 *µ*m-thick horizontal sections from E12.5 *Hb9-EGFP;Fz3*^*+/−*^ (**T**) and *Hb9-EGFP;Fz3*^*−/−*^ (**T′**) heads. Scale bar, 500 *µ*m. (**U** and **U′**) The VI^th^ nerve visualized by GFP immunostaining on 700 *µ*m-thick horizontal sections from E13.5 *Hb9-EGFP;Fz3*^*+/-*^ (**U**) and *Hb9-EGFP;Fz3*^*−/−*^ (**U′**) embryos. Scale bar, 500 *µ*m.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.005](10.7554/eLife.01482.005)10.7554/eLife.01482.006Figure 2---figure supplement 2.The V^th^ (trigeminal) motor nerve and its target innervation are not affected by loss of *Fz3*.(**A**) The V^th^ motor nuclei and nerves visualized by AP staining on continuous coronal sections from E18.5 *ChAT-IRES-Cre;R26iAP;Fz3*^*+/−*^ (a--g) and *ChAT-IRES-Cre;R26iAP;Fz3*^*−/−*^ (a′--g′) mouse heads. V^th^ motor nuclei and axon tracts/nerves are indicated by arrows and arrowheads, respectively. Panels (c--g) and (c′--g′) here match panels (a--e) and (a′--e′), respectively, in (**G**), with a small vertical offset. Scale bar, 1 mm. (**B**--**C′**) Innervation of muscles of mastication by the V^th^ motor nerve visualized by AP staining on coronal sections from E18.5 *ChAT-IRES-Cre;R26iAP;Fz3*^*+/−*^ (**B** and **C**) and *ChAT-IRES-Cre;R26iAP;Fz3*^*−/−*^ (**B′** and **C′**) mouse heads. Scale bar, 1 mm. (**D**--**F′**) Cholinergic axons within the retro-orbital and palatal regions in sagittal (**D** and **D′**) and coronal (**E**--**F′**) sections. In *Fz3*^*−/−*^ embryos, the number of axons is reduced (green arrows in \[**D**--**F**\] vs red arrows in \[D′--F′\]). Scale bars, 1 mm. (**G**) The VII^th^ motor nucleus and nerve in consecutive coronal sections. The majority of *Fz3*^*−/−*^ VII^th^ motor neurons fail to migrate cadually to rhombomere 6. Arrows, VII^th^ motor nuclei; arrowheads, VII^th^ motor axons. Scale bar, 1 mm. (**H**--**I′**) The dorsal motor nucleus of the X^th^ nerve (blue and orange arrows), the motor nucleus of the XII^th^ nerve (green and red arrows), and axons from these nuclei (arrowheads, same color scheme) in consecutive coronal (**H**a--d′) and sagittal (**I** and **I′**) sections. Scale bars, 1 mm. (**J** and **K**) Diagrams showing the planes of sections in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} (**J**) at E18.5 (left) and E12.5 and E13.5 (right), and in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} (K).**DOI:** [http://dx.doi.org/10.7554/eLife.01482.006](10.7554/eLife.01482.006)

AP-stained serial sections from *ChAT-IRES-Cre*;*R26iAP*;*Fz3*^*+/−*^ and *ChAT-IRES-Cre*;*R26iAP*;*Fz3*^*−/−*^ embryos at E18.5 revealed a diverse array of defects among cholinergic neurons and fibers in the brainstem and periphery ([Figure 2C--I′](#fig2){ref-type="fig"}, and [Figure 2---figure supplements 1 and 2](#fig2s1 fig2s2){ref-type="fig"}). These include: (1) impaired caudal migration of neurons comprising the VII^th^ motor nucleus and a loss of motor innervation to the face ([Figure 2C--E′](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2G](#fig2s2){ref-type="fig"}); (2) diminished staining of cholinergic nerves within the palate and retro-orbital fissure ([Figure 2---figure supplement 2D--F′](#fig2s2){ref-type="fig"}); and (3) decreased motor innervation of the tongue by the XII^th^ nerve ([Figure 2F--G′](#fig2){ref-type="fig"}). The defect in migration of VII^th^ motor neurons is consistent with that reported by [@bib55]. We also observed a nearly complete loss of cholinergic neurons in the vomeronasal organ ([Figure 2H--I′](#fig2){ref-type="fig"}). By contrast, the III^rd^-VI^th^, X^th^ and XII^th^ motor nuclei appear unaltered in *ChAT-IRES-Cre*;*R26iAP*;*Fz3*^*−/−*^ embryos and the trajectories of their axons appear to be normal ([Figure 2---figure supplements 1 and 2](#fig2s1 fig2s2){ref-type="fig"}).

The *ChAT-IRES-Cre*;*R26iAP* reporter showed decreased innervation of the *Fz3*^*−/−*^ diaphragm ([Figure 2J--M′](#fig2){ref-type="fig"}), consistent with the analysis presented in [Figure 1D--H′′](#fig1){ref-type="fig"}. The phrenic nerve defects may contribute to the respiratory distress that kills *Fz3*^*−/−*^ neonates. A second contributing factor may be the disorganization of axons in the vicinity of the Pre-Bötzinger complex (data not shown), the brainstem region that coordinates respiratory movements by controlling the activity of the phrenic motor column ([@bib65]).

Impaired migration of a subset of neural crest cells in *Fz3*^*−/−*^ embryos {#s2-3}
----------------------------------------------------------------------------

By NF immunostaining of whole-mount E12 embryos, [@bib74] observed a series of discrete NF-rich clusters along the caudal half of the *Fz3*^*−/−*^ spinal cord that appear to represent ectopic neurons ([Figure 3A,A′](#fig3){ref-type="fig"}). Based on their dorsal midline location, we hypothesized that these clusters might arise from neural crest (NC) cells that had failed to migrate from their origin in the dorsal neural tube. To test this hypothesis, we asked whether cells in these clusters express transcription factors characteristic of NC derivatives. For example, Sox10 expression is detected in migrating NC cells and persists in melanocytes and a subset of dorsal root ganglion (DRG) neurons, and Brn3a and Islet1/2 are expressed in postmigratory DRG sensory neurons ([@bib45]; [@bib59]; [@bib8]).10.7554/eLife.01482.007Figure 3.Neural crest cell migration defects in *Fz3^−/−^* mice.(**A** and **A′**) NF immunostaining of whole-mount E11 embryos showing aberrant clusters of neurons along the dorsal edge of the caudal neural tube in *Fz3*^*−/−*^ embryos. Scale bar, 500 *µ*m. (**B**--**C′′**) Islet1/2, Brn3a, and Sox10 immunostaining in cross sections of the NF-rich clusters in *Fz3*^*−/−*^ neural tubes at E12.5. Scale bars, 100 *µ*m. (**D**--**F′′**) NF, cleaved Caspase3, and Sox10 immunostaining in cross sections of early E11.5 *Fz3*^*+/−*^ (**D**--**D′′**) and *Fz3*^*−/−*^ (**E**--**E′′**) spinal cords. The boxed regions in (**E**--**E′′**) are enlarged in (**F**--**F′′**). Scale bars: (**E′′**), 200 *µ*m; (**F′′**), 100 *µ*m.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.007](10.7554/eLife.01482.007)

As shown in [Figure 3B--C′′](#fig3){ref-type="fig"}, almost all of the cells in the NF-rich clusters express Sox10, Brn3a, or Islet1/2, consistent with a NC origin. Interestingly, Sox10 and Brn3a are expressed in mutually exclusive subsets of cells, as are Sox10 and Islet1/2, suggesting that despite their migratory defect, these presumptive NC cells are able to differentiate along appropriate committed lineages. Furthermore, Sox10 and NF immunolabeling within the dorsal clusters appear to be mutually exclusive or nearly so ([Figure 3E′′,F′′](#fig3){ref-type="fig"}), suggesting that at E11.5 the dorsal clusters consist of two classes of cells: immature NC cells at the migratory stage (Sox10^+^/NF^-^/Brn3a^−^/Islet1/2^−^) and more mature NC cells that are differentiating as DRG neurons (Sox10^−^/NF^+^/Brn3a^+^/Islet1/2^+^). These observations suggest that NC cell differentiation can proceed in the absence of cell migration, and that these dorsal clusters could serve as a useful model for dissecting extrinsic vs intrinsic influences on NC cell specification.

We further observed that both the number and average size of the dorsal clusters decreased from E11.5 to E12.5 and they completely disappeared by ∼E14.5, suggesting that the ectopic cells undergo programmed cell death. As shown in [Figure 3D--F′′](#fig3){ref-type="fig"}, at E11.5 many cells in the dorsal clusters contain activated Caspase3, especially those that are Sox10^−^/NF^+^. Activated Caspase3 is largely absent from Sox10^+^/NF^−^ cells. Apparently the more differentiated DRG-like dorsal cluster neurons are the first to undergo apoptotic cell death, and the less differentiated NC derivatives are temporarily spared that fate.

In the lumbar region of E11.5 *Fz3*^*−/−*^ embryos, there is a ∼0.5 day delay in the appearance of apoptotic neurons within the DRG, as determined by immunostaining for activated Caspase3, relative to *Fz3*^*+/−*^ littermates (compare [Figure 3D,D′](#fig3){ref-type="fig"} vs [Figure 3E,E′](#fig3){ref-type="fig"}). This delay in apoptotic death among DRG neurons is not observed in the cervical region of E11.5 *Fz3*^*−/−*^ embryos, which is devoid of dorsal clusters. In DRGs, NC cells differentiate into neurons in greater numbers than are required for full target innervation, and the resulting competition for target-derived survival factors leads to the death of excess neurons ([@bib51]; [@bib12]). Since apoptotic cell death in *WT* DRGs is well underway by E11.5, when most DRG axons are still far from their final targets, it is likely that intermediate targets are a major source of survival signals. The similar distributions along the spinal cord of dorsal clusters and delayed apoptosis suggested the possibility that in the lumber region of *Fz3*^*−/−*^ embryos there may be an initial reduction in the number of NC cells arriving at the DRG, leading to decreased competition for peripheral targets and higher rates of survival of DRG neurons.

*Fz3* loss-of-function results in severe thinning of the spinal motor nerve innervating the dorsal limb {#s2-4}
-------------------------------------------------------------------------------------------------------

In light of the essential role of *Fz3* in the development of subsets of cranial motor neurons, we evaluated the role of *Fz3* in the development of spinal motor neurons that innervate the limbs, a set for which the axonal projection patterns have been well defined ([@bib14]; [@bib10]). NF immunostaining of E11.5-E13.5 limbs showed that the nerve innervating the dorsal limb is moderately thinned in *Fz3*^*−/−*^ forelimbs and moderately to severely thinned in *Fz3*^*−/−*^ hindlimbs ([Figure 4A--H′](#fig4){ref-type="fig"}, and [Figure 4---figure supplements 1 and 2](#fig4s1 fig4s2){ref-type="fig"}). In the hindlimb, roughly 50% of *Fz3*^*−/−*^ embryos exhibit a moderate defect, with a thinned dorsal nerve that is still visible along its distal trajectory. The remaining ∼50% of *Fz3*^*−/−*^ embryos exhibit a severe defect, with a near absence of the dorsal nerve. Other nerves within the limb appear to be largely unaffected.10.7554/eLife.01482.008Figure 4.Thinning of the dorsal motor nerve in *Fz3*^*−/−*^ limbs.(**A**) Diagram showing dorsal (D) and ventral (V) limb innervation by spinal motor nerves in control (*WT* or *Fz3*^*+/−*^; top) and *Fz3*^*−/−*^ (bottom) embryos. In *Fz3*^*−/−*^ limbs, the dorsal nerve is thinned distal to the plexus at the base of the limb (highlighted by arrows). SC, spinal cord. (**B**--**F′**) NF immunostaining of whole-mount fore- and hindlimbs from E13.5 *Fz3*^*+/−*^ and *Fz3*^*−/−*^ embryos. (**B′**--**F′**), magnified view of boxed regions in (**B**--**F**). Arrows (control) and arrowheads (mutant) indicate dorsal nerves, which are moderately thinner in *Fz3*^*−/−*^ forelimbs and substantially thinner in *Fz3*^*−/−*^ hindlimbs. Asterisks indicate the points at which axons stall in *Fz3*^*−/−*^ limbs. The red to blue color code represents depth within the Z-stack, oriented here along the dorsal to ventral axis. Scale bars: (**B**--**F**), 500 *µ*m; (**B**′--**F**′), 100 *µ*m. (**G**--**H**′) NF immunostaining of 1 mm-thick sections in the dorsoventral plane encompassing fore- or hindlimbs from E12.5 *Fz3*^*+/−*^ and *Fz3*^*−/−*^ embryos. Arrows (control) and arrowheads (*Fz3*^*−/−*^) indicate dorsal nerves, which are thinner in *Fz3*^*−/−*^ limbs. Asterisks indicate the points at which axons stall in *Fz3*^*−/−*^ limbs. Red to blue color code represents depth within the Z-stack, oriented here along the rostrocaudal axis. P, proximal; D, distal. Scale bars, 500 *µ*m. (**I**--**L′′**) GFP (green) and NF (red) double immunostaining of whole-mount forelimbs and hindlimbs from E12.5 *Hb9-EGFP;Fz3*^*+/+*^ and *Hb9-EGFP*;*Fz3*^*−/−*^ embryos (**I**--**L**). Motor axons (labeled with GFP) are selectively eliminated from the dorsal nerve in mutant limbs (arrowheads and arrows). (**I′**--**L′**) are enlarged views of the NF immunostaining in the boxed regions in (**I**--**L**), with color representing depth along the dorsoventral axis. Similarly, (**I′′**--**L′′**) are enlarged views of the GFP immunostaining. P, proximal; D, distal; d, dorsal; i, intermediate; v, ventral. Scale bars: (**J**) and (**L**), 500 *µ*m; (**J′′**) and (**L′′**), 100 *µ*m. (**M**) Diagrams showing the locations of nerve diameter measurements quantified in (**N**), traced from images (**B′**) and (**D′**). The locations of two dorsal nerve measurements (D~Distal~, dorsal nerve diameter measured immediately distal to the stalling point; D~Proximal~, dorsal nerve diameter measured immediately proximal to the stalling point) and one ventral nerve measurement (V) are shown. Scale bar, 100 *µ*m. (**N**) The diameters of motor nerves at the locations shown in (**M**) were measured from NF immunostained whole-mount forelimbs (top) and hindlimbs (bottom) from two litters at E12.5 and one litter at E13.5. Bars, mean ± SEM. p-values are shown for the indicated pair-wise comparisons (student's *t*-test).**DOI:** [http://dx.doi.org/10.7554/eLife.01482.008](10.7554/eLife.01482.008)10.7554/eLife.01482.009Figure 4---figure supplement 1.Thinning of spinal motor nerves innervating the dorsal forelimb.(**A**--**L′**) NF immunostaining on whole-mount forelimbs from E13.5 *WT* or *Fz3*^*+/−*^ (**A**--**F**) and *Fz3*^*−/−*^ (**G**--**L**) embryos, with depth coded by colors as in [Figure 4B--F′](#fig4){ref-type="fig"}. (**A′**--**L′**) are magnified views of the boxed regions in (**A**--**L**). Scale bars: (**F**) and (**L**), 500 *µ*m; (**F′**) and (**L′**), 100 *µ*m.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.009](10.7554/eLife.01482.009)10.7554/eLife.01482.010Figure 4---figure supplement 2.Thinning of spinal motor nerves innervating the dorsal hindlimb.(**A**--**L′**) NF immunostaining on whole-mount hindlimbs from E13.5 *WT* or *Fz3*^*+/−*^ (**A**--**F**) and *Fz3*^*−/−*^ (**G**--**L**) embryos, with depth coded by colors as in [Figure 4B--F′](#fig4){ref-type="fig"}. (**A′**--**L′**) are a magnified view of the boxed regions in (**A**--**L**). Scale bars: (**F**) and (**L**), 500 *µ*m; (**F′**) and (**L′**), 100 *µ*m. (**M**) Number of dorsal nerves with different categories of phenotypes in *WT* and *Fz3*^*+/−*^ vs *Fz3*^*−/−*^ forelimbs and hindlimbs.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.010](10.7554/eLife.01482.010)10.7554/eLife.01482.011Figure 4---figure supplement 3.Loss of *Fz3* does not affect axial or body wall motor nerve trajectories.(**A** and **A′**) NF immunostaining on whole-mount anterior body wall encompassing the thorax/abdomen junction from E13.5 *WT* (**A**) and *Fz3*^*−/−*^ (**A′**) embryos. Scale bar, 1 mm. (**B**--**E′**) NF and GFP immunostaining on 700 *µ*m-thick cross sections from E12.5 *Hb9-EGFP;Fz3*^*+/−*^ (**B**--**B′′**, **D**, and **E**) and *Hb9-EGFP;Fz3*^*−/−*^ (**C**--**C′′**, **D′**, and **E′**) embryos. Boxed regions in (**B**) are enlarged in (**D**) and (**E**). Boxed regions in (**C**) are enlarged in (**D′**) and (**E′**). (**D**) and (**D′**) show axial motor nerves, and (**E**) and (**E′**) show anterior body wall motor nerves. Scale bars, 500 *µ*m.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.011](10.7554/eLife.01482.011)

To ascertain the motor vs sensory identity of the affected axons, we crossed the *Hb9-EGFP* transgene to *Fz3* mutant mice to selectively label motor axons. GFP immunostaining of *Hb9-EGFP;Fz3*^*+/+*^ and *Hb9-EGFP;Fz3*^*−/−*^ limbs at E12.5 showed that motor axons are severely under-represented in the dorsal nerve in both fore- and hindlimbs in mutant embryos ([Figure 4I--L′′](#fig4){ref-type="fig"}). The affected axons derive from motor neurons in the lateral division of the lateral motor column (LMC~L~; [Figure 4A](#fig4){ref-type="fig"}).

Close examination of the pattern of NF immunostaining showed that the *Fz3*^*−/−*^ defect occurs distal to the point where LMC axons separate into dorsal and ventral nerves. More specifically, in *Fz3*^*−/−*^ limbs an abrupt decrease in diameter is observed in the dorsal nerve immediately distal to the emergence of its first major side branch ([Figure 4B′--H′,M](#fig4){ref-type="fig"}). Therefore, the defect in the *Fz3*^*−/−*^ limb appears to be a stalling of LMC~L~ axons at this location. To quantify this phenotype, we measured the thickness of the dorsal nerve proximal and distal to this point. We also measured the thickness of the ventral nerve at the same distance from the plexus ([Figure 4M](#fig4){ref-type="fig"}). All measurements were made on NF-immunostained whole-mount limbs viewed in a dorsal-to-ventral orientation. [Figure 4N](#fig4){ref-type="fig"} shows the quantification of nerve thickness for fore- and hindlimbs among littermates in two E12.5 litters and one E13.5 litter. In [Figure 4N](#fig4){ref-type="fig"}, moderate and severe phenotypes within the hindlimb are represented by distinct symbols, but the statistical analysis ignores this distinction and simply compares *Fz3*^*+/−*^ and *Fz3*^*+/+*^ vs *Fz3*^*−/−*^ littermates. For both the fore- and hindlimbs in *Fz3*^*−/−*^ embryos, several findings emerge: (1) the thinning of the dorsal nerve is highly significant statistically and it occurs over a remarkably small interval, between the regions labeled D~Proximal~ and D~Distal~ in [Figure 4M](#fig4){ref-type="fig"}; (2) proximal to position D~Proximal~, dorsal nerve thinning is minimal and statistically insignificant; (3) the ventral nerve exhibits a small decrease in thickness in 5/6 comparisons, with 4/6 showing a difference that is statistically significant (p\<0.05), implying that dorsal nerve axons have not rerouted to the ventral nerve, which would have then shown an increase in thickness; and (4) the average nerve thickness, relative to the littermate controls, is 31% for the dorsal nerve in the hindlimb, 57% for the dorsal nerve in the forelimb, and 82% for the ventral nerve when averaged over fore- and hindlimbs.

In *Fz3*^*−/−*^ embryos, other classes of spinal motor axons appear to be unaffected, including medial motor column and hypaxial motor column axons that innervate axial muscles and body wall muscles, respectively ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Although *Fz3* is widely expressed in the mouse spinal cord and brainstem, it appears to be uniquely required by only a subset of motor neurons.

*Fz3* controls axon growth of LMC~L~ motor neurons {#s2-5}
--------------------------------------------------

We next asked whether the primary cause of motor axon deficiency in the VII^th^, XII^th^, phrenic, and dorsal limb nerves in *Fz3*^*−/−*^ mice is: (1) defective motor neuron differentiation, (2) excessive motor neuron death, or (3) defective axon growth and/or guidance. Since the vast majority of *Fz3*^*−/−*^ motor axons do not appear to follow erroneous trajectories ([Figures 1A,A′, and 4](#fig1 fig4){ref-type="fig"}), aberrant path-finding is unlikely to be relevant. There are also no apparent defects in motor axon fasciculation in *Fz3*^*−/−*^ embryos ([Figures 1 and 4](#fig1 fig4){ref-type="fig"}). To distinguish among the remaining possibilities, we focused on LMC~L~ motor neurons and their axons, because (1) these neurons can be unambiguously identified based on their patterns of transcription factor expression; (2) their axons can be clearly identified within the limb; and (3) several signaling pathways that control LMC~L~ axon growth and guidance decisions provide points of comparison.

In the developing mouse spinal cord, postmitotic motor neurons are generated between E9 and E11 ([@bib2]). Motor neurons are divided into pools positioned at stereotypical locations along the rostrocaudal, dorsoventral, and mediolateral axes of the spinal cord. Each motor pool innervates specific peripheral targets and can be characterized by the expression of various transcription factors ([@bib10]). For example, Islet1 is expressed by LMC~M~ motor neurons and Lhx1 is expressed by LMC~L~ motor neurons, while Islet2 and Foxp1 are pan-LMC markers ([Figure 5A](#fig5){ref-type="fig"}). By using Islet1 and Foxp1 double immunostaining on cross sections from E11.5 lumbar-level spinal cords we observed that the LMC~L~ pool (Foxp1^+^/Islet1^−^) is present in *Fz3*^*−/−*^ mice ([Figure 5B,B′](#fig5){ref-type="fig"}). This result implies that *Fz3* is not required for the initial specification of LMC~L~ motor neurons.10.7554/eLife.01482.012Figure 5.Abundance, differentiation, and apoptosis of motor neurons in *Fz3*^*−/−*^ embryos, and the effects of suppressing apoptosis.(**A**) Diagram showing the pattern of transcription factor expression in LMC~L~ and LMC~M~ motor neurons. SC, spinal cord; D, dorsal; V, ventral. (**B** and **B′**) Islet1 and Foxp1 expression in spinal motor neurons in cross sections of E11.5 *Fz3*^*+/−*^ and *Fz3*^*−/−*^ lumbar spinal cords. Continuous white line, lateral edge of the spinal cord. The broken white line encircles LMC~M~ motor neurons. L, lateral; M, medial. Scale bar, 100 *µ*m. (**C** and **C′**) The number of LMC~L~ (Islet1^−^/Foxp1^+^) and LMC~M~ (Islet1^+^/Foxp1^+^) motor neurons per 14 *µ*m frozen section in E12.5 *Fz3*^*+/−*^ and *Fz3*^*−/−*^ lumbar spinal cords. Motor neurons were counted and averaged from 12 serial sections from each of three pairs of embryos, with adjacent counted sections separated by four uncounted sections. (**D**--**E′′**) Motor neuron apoptosis visualized with Islet1/2 and cleaved Caspase3 immunostaining in cross sections of E11.5 *Fz3*^*+/−*^ (arrows) and *Fz3*^*−/−*^ (arrowheads) lumbar spinal cords. Scale bar, 500 *µ*m. (**F**--**G′′**) Reduced LMC volume in the *Fz3*^*−/−*^ lumbar spinal cord visualized by comparing Islet1/2 and Foxp1 immunostaining in cross sections of E12.5 *Fz3*^*+/−*^ (arrows) and *Fz3*^*−/−*^ (arrowheads) lumbar spinal cords. Scale bar, 500 *µ*m. (**H**--**L**) Cell death in VII^th^ (**H**--**I′**), and XII^th^ (**J**--**K′**) cranial motor nuclei (arrows and arrowheads) visualized with cleaved Caspase3 and NF immunostaining in horizontal sections of E12.5 *Fz3*^*+/−*^ and *Fz3*^*−/−*^ embryos. (**H′**--**K′**) show cleaved Caspase3 immunostaining with DAPI counterstaining for (**H**--**K**). (**L**) planes of section. Scale bar, 100 *µ*m. (**M**--**R′**) NF immunostaining of whole-mount forelimbs (**M**--**O′**) and hindlimbs (**P**--**R′**) from E12.5 *Bax*^*+/−*^, *Fz3*^*−/−*^*;Bax*^*−/−*^, and *Fz3*^*−/−*^*;Bax*^*+/−*^ embryos. For each pair of panels, the inset in the upper panel is enlarged in the lower panel. Arrows and arrowheads indicate the dorsal nerve. Depth is color coded as in [Figure 4B--F′](#fig4){ref-type="fig"}. Scale bars: (**R**), 500 *µ*m; (**R′**), 100 *µ*m.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.012](10.7554/eLife.01482.012)10.7554/eLife.01482.013Figure 5---figure supplement 1.Precocious motor neuron death in *Fz3^−/−^* spinal cord is blocked by loss of *Bax*.(**A**--**B′′**) Cell death in the ventral spinal cord at the brachial level visualized by cleaved Caspase3 and NF immunostaining on cross sections of E11.5 *Fz3*^*+/−*^ (**A**--**A′′**) and *Fz3*^*−/−*^ (**B**--**B′′**) embryos. In contrast to the ventrolateral spinal cord, there is no effect of *Fz3* loss on cell death in the DRG. Scale bar, 500 *µ*m. (**C**--**D′′**) Cell death in the ventral spinal cord at the lumbar level visualized by cleaved Caspase3 and NF immunostaining on cross sections of E12.5 *Fz3*^*+/−*^ (**C**--**C′′**) and *Fz3*^*−/−*^ (**D**--**D′′**) embryos. In contrast to the ventrolateral spinal cord, there is no effect of *Fz3* loss on cell death in the DRG. Scale bar, 500 *µ*m. (**E**--**G′′′**) Caspase3 and Islet1/2 immunostaining on cross sections from E12.5 *Fz3*^*+/−*^ (**E**--**E′′′**), *Fz3*^*−/−*^ (**F**--**F′′′**), and *Fz3*^*−/−*^*;Bax*^*−/−*^ (**G**--**G′′′**) lumbar spinal cords. Boxed regions in (**E**--**G**) are enlarged in (**E′′′**--**G′′′**). Loss of *Bax* suppresses cell death in both the DRG and spinal cord. Scale bars: (**G**), 500 *µ*m; (**G′′′**), 100 *µ*m.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.013](10.7554/eLife.01482.013)

To quantitatively assess motor neuron populations at a time when the *Fz3*^*−/−*^ phenotype is fully manifest, we counted the number of LMC~L~ neurons in serial cross sections from E12.5 lumbar-level spinal cords following Islet1 and Foxp1 immunostaining of three pairs of control and *Fz3*^*−/−*^ littermate embryos. As both LMC~M~ and LMC~L~ neurons were counted in the same sections, the number of LMC~M~ neurons served as an internal control. As shown in [Figure 5C,C′](#fig5){ref-type="fig"}, in the region of the *Fz3*^*−/−*^ spinal cord that contains LMC~L~ neurons, the number of LMC~L~ neurons was significantly decreased, while the number of LMC~M~ neurons was similar to that in *Fz3*^*+/−*^ controls (sections 1--6). In contrast, the numbers of both LMC~M~ and LMC~L~ neurons in more rostral regions were unaffected by loss of *Fz3* (sections 7--12).

The decrease in LMC~L~ neurons at E12.5 suggests that loss of *Fz3* could lead---directly or indirectly---to LMC~L~ motor neuron death. To test this possibility, we performed cleaved Caspase3 immunostaining on lumbar spinal cord sections from embryos at E11.5 and E12.5, developmental stages prior to the wave of naturally occurring motor neuron death at E13.5-E15.5 ([@bib35]; [@bib52]). As expected, very few apoptotic cells were observed in *Fz3*^*+/−*^ controls at E11.5 and E12.5. In contrast, massive cell death is seen in the region corresponding to the LMC in the brachial and lumbar regions of the *Fz3*^*−/−*^ spinal cord ([Figure 5D--E′′](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1A--D′′](#fig5s1){ref-type="fig"}). By E12.5 the lumbar LMC volume is substantially smaller in *Fz3*^*−/−*^ compared with *Fz3*^*+/−*^ spinal cords ([Figure 5F--G′′](#fig5){ref-type="fig"}). Similarly, in the VII^th^ and XII^th^ cranial nerve nuclei at E12.5, there is an analogous wave of precocious motor neuron death that is not observed in *Fz3*^*+/−*^ controls ([Figure 5H--K′](#fig5){ref-type="fig"}). Thus, in *Fz3*^*−/−*^ embryos a discrete subset of motor neurons exhibits both axon growth defects and apoptotic cell death at E11.5-E12.5.

The results thus far indicate that *Fz3* inactivation could lead either to a primary defect in motor neuron viability that secondarily impairs axonal growth or a primary defect in axonal growth that secondarily impairs motor neuron viability. To distinguish these two possibilities, we used a *Bax*^*−/−*^ background---in which loss of the proapoptotic molecule *Bax* largely eliminates apoptosis of motor neurons ([@bib75])---to ask whether blocking (or delaying) motor neuron apoptosis rescues the *Fz3*^*−/−*^ dorsal nerve defect. Although the precocious motor neuron death seen in *Fz3*^*−/−*^ embryos was eliminated in *Bax*^*−/−*^*;Fz3*^*−/−*^ embryos, the dorsal nerve defect at the base of the limbs remained unchanged ([Figure 5M--R′](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1E--G′′′](#fig5s1){ref-type="fig"}). Taken together, these data imply that in spinal motor neurons the primary phenotype resulting from loss of *Fz3* is a defect in the growth of LMC~L~ axons. Since apoptosis is restricted to precisely those motor neurons that exhibit defective axonal growth and since the axonal growth defect is not secondary to apoptosis of LMC~L~ neurons, it seems very likely that the chain of causality leads from the axonal growth defect to apoptosis.

*Fz3* expression is required in the CNS but not in the periphery to control axon growth {#s2-6}
---------------------------------------------------------------------------------------

We next asked whether the axonal phenotypes in *Fz3*^*−/−*^ embryos reflect *Fz3* action exclusively in CNS neurons. Based on the pattern of *lacZ* reporter expression from the original *Fz3* null allele (which carries an in-frame *lacZ* open reading frame), *Fz3* expression appears to be far higher in the CNS than in other tissues ([@bib72]). However, rigorously answering this question requires selective inactivation of *Fz3* in defined cell populations. To that end, we generated a *Fz3* conditional allele (*Fz3*^*CKO*^), in which *LoxP* sites flank exon 3, the largest coding exon, within the *Fz3* gene ([Figure 6---figure supplement 1A,B](#fig6s1){ref-type="fig"}). Following Cre-mediated recombination, the exon 3-deleted allele behaves as a null (data not shown). To eliminate *Fz3* expression exclusively in CNS neurons, we controlled recombination with an *Olig2*^*Cre*^ knock-in allele and found that *Olig2*^*Cre/+*^*;Fz3*^*CKO/−*^ mice exhibit the complete spectrum of motor neuron phenotypes shown by *Fz3*^*−/−*^ mice: (1) VII^th^ nerve axons do not form the well-defined C-shaped tract looping around the VI^th^ cranial nerve nucleus ([Figure 6A,A′](#fig6){ref-type="fig"}); (2) the XII^th^ cranial nerve is markedly thinned and fails to innervate the tongue at E13.5 ([Figure 6B--C′](#fig6){ref-type="fig"}); (3) the phrenic nerve is thinned ([Figure 6D,D′](#fig6){ref-type="fig"}); and (4) the dorsal nerves innervating the fore- and hindlimbs are thinned ([Figure 6E--H′](#fig6){ref-type="fig"}). This experiment rules out any role for Fz3 in peripheral tissues. *Fz3* expression in DRG neurons also appears to be irrelevant since *Olig2*^*Cre*^ is not expressed in DRG neurons ([@bib32]; [@bib11]), a conclusion that was further confirmed by inactivating the *Fz3*^*CKO*^ allele specifically in DRG neurons with a *Wnt1-Cre* transgene (*Wnt1-Cre*;*Fz3*^*CKO/−*^; [@bib13]) and observing that the dorsal nerves innervating the fore- and hindlimbs were unaffected ([Figure 6---figure supplement 1C--D′](#fig6s1){ref-type="fig"}). These data imply that the LMC~L~ motor axon defect is not an indirect consequence of Fz3-dependent effects on co-fasciculating sensory axons.10.7554/eLife.01482.014Figure 6.*Olig2^Cre/+^;Fz3^CKO/−^* embryos recapitulate the motor neuron phenotype of *Fz3^−/−^* embryos.(**A** and **A′**) The VII^th^ cranial nerve axons visualized by NF immunostaining of horizontal sections through E12.5 *Olig2*^*Cre/+*^*;Fz3*^*CKO/+*^ (arrow) and *Olig2*^*Cre/+*^*;Fz3*^*CKO/−*^ (arrowhead) brainstems. In the *Olig2*^*Cre/+*^*;Fz3*^*CKO/−*^ brainstem, the more rostromedial locations of the VII^th^ nerve cell bodies are apparent, and the VII^th^ nerve axons fail to loop around the VI^th^ cranial nerve nucleus. C, caudal; R, rostral. Scale bar, 500 *µ*m. (**B** and **B′**) The XII^th^ cranial nerve visualized by NF immunostaining in lateral views of whole-mount E11.5 *Olig2*^*Cre/+*^*;Fz3*^*CKO/+*^ (arrow) and *Olig2*^*Cre/+*^*;Fz3*^*CKO/−*^ (arrowhead) embryos. The XII^th^ nerve has a reduced diameter in *Olig2*^*Cre/+*^*;Fz3*^*CKO/−*^ embryos. Scale bar, 500 *µ*m. (**C** and **C′**) Innervation of tongue muscles by the XII^th^ cranial nerve visualized by GFP immunostaining in coronal sections of early E13.5 *Hb9-EGFP;Olig2*^*Cre/+*^*;Fz3*^*CKO/+*^ (arrows) and *Hb9-EGFP;Olig2*^*Cre/+*^*;Fz3*^*CKO/−*^ (arrowheads) embryos. The *Hb9-EGFP;Olig2*^*Cre/+*^*;Fz3*^*CKO/−*^ tongue shows no motor innervation. A, apical; B, basal. Scale bar, 500 *µ*m. (**D** and **D′**) The phrenic nerve visualized by NF immunostaining in lateral views of whole-mount E11.5 *Olig2*^*Cre/+*^*;Fz3*^*CKO/+*^ (arrow) and *Olig2*^*Cre/+*^*;Fz3*^*CKO/−*^ (arrowhead) embryos. The phrenic nerve has a reduced diameter in *Olig2*^*Cre/+*^*;Fz3*^*CKO/−*^ embryos. Scale bar, 500 *µ*m. (**E**--**H′**) NF immunostaining of whole-mount forelimbs (**E** and **F**) and hindlimbs (**G** and **H**) from E12.5 *Fz3*^*CKO/−*^ and *Olig2*^*Cre/+*^*;Fz3*^*CKO/−*^ embryos. Boxed regions in (**E**--**H**) are enlarged in (**E′**--**H′**). Arrows and arrowheads indicate the dorsal nerve. Depth is color coded as in [Figure 4B--F′](#fig4){ref-type="fig"}. Scale bars: (**H**), 500 *µ*m; (**H′**), 100 *µ*m.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.014](10.7554/eLife.01482.014)10.7554/eLife.01482.015Figure 6---figure supplement 1.Design of the *Fz3^CKO^* allele, and limb innervation in *Wnt1-Cre;Fz3^CKO/−^* mice.(**A**) Structure of the *Fz3*^*CKO*^ allele. Top, partial genomic map of the third *Fz3* coding exon. The exon is indicated by a filled rectangle, and cutting sites for *EcoR* I and *EcoR* V are shown. Middle, structure of the *Fz3*^*CKO*^ targeting construct. Bottom, map of the allele after homologous recombination, and locations of Southern blot hybridization probes. (**B**) Genotyping of *WT* and *Fz3*^*CKO/+*^ mice by Southern blotting with the flanking 5′ and 3′ probes shown in (**A**) after *EcoR* I digestion. The sizes of genomic fragments generated by *WT* and targeted alleles are indicated. (**C**--**D′**) NF immunostaining on whole-mount forelimbs (**C** and **C′**) and hindlimbs (**D** and **D′**) from E12 *Fz3*^*CKO/+*^ (**C** and **D**) and *Wnt1-Cre;Fz3*^*CKO/−*^ (**C′** and **D′**) embryos, with depth coded by color as in [Figure 4B--F′](#fig4){ref-type="fig"}. Scale bar, 500 *µ*m.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.015](10.7554/eLife.01482.015)

Defects in peroneal nerve development in *Fz3*^*−/−*^ mice lead to atrophy of anterior compartment muscles in the distal hindlimb {#s2-7}
---------------------------------------------------------------------------------------------------------------------------------

The perinatal death of *Fz3*^*−/−*^ mice has, until now, prevented an analysis of the *Fz3*^*−/−*^ phenotype in postnatal life. To circumvent this problem, we combined a *Caudal-1* (*Cdx1)-Cre* transgene with the *Fz3*^*CKO*^ allele to inactivate *Fz3* in all tissues caudal to the upper thorax before midgestation ([@bib27]). The postnatal viability of *Cdx1-Cre;Fz3*^*CKO/−*^ mice implies that structures critical for breathing and feeding develop normally. Like *Fz3*^*−/−*^ embryos at E18.5, *Cdx1-Cre;Fz3*^*CKO/−*^ mice exhibit plantar-flexed hindlimbs and a curled tail ([Figure 7A](#fig7){ref-type="fig"}; compare to [Figure 2](#fig2){ref-type="fig"} of [@bib72]). In *Cdx1-Cre;Fz3*^*CKO/−*^ embryos at E12.5, the thinning of the dorsal nerve in fore- and hindlimbs is indistinguishable from the thinning observed in *Fz3*^*−/−*^ embryos ([Figure 7B--E′](#fig7){ref-type="fig"}).10.7554/eLife.01482.016Figure 7.Selective hindlimb muscle atrophy in response to the failure of motor innervation in *Fz3^−/−^* mice.(A) P11 *Cdx1-Cre;Fz3*^*CKO/−*^ mouse exhibiting severe plantar flexion of the hind feet (arrows) and a curled tail (arrowhead). (**B**--**E′**) NF immunostaining of whole-mount forelimbs and hindlimbs from E12.5 *Fz3*^*CKO/+*^ and *Cdx1-Cre;Fz3*^*CKO/−*^ embryos. (**B′**--**E′**) are magnified views of the boxed regions in (**B**--**E**). Arrows and arrowheads indicate the dorsal nerve. Depth is color coded as in [Figure 4B--F′](#fig4){ref-type="fig"}. Scale bars: (**E**), 500 *µ*m; (**E′**), 100 *µ*m. (**F** and **F′**) In E15.5 *Hb9-EGFP;Cdx1-Cre;Fz3*^*CKO/−*^ distal hindlimbs, the anterior compartment musculature (tibialis anterior, extensor hallucis longus, and extensor digitorum longus; delimited by a white border) lacks motor innervation as visualized by GFP immunostaining. Extensive motor innervation is seen in the *Hb9-EGFP;Fz3*^*CKO/−*^ littermate control that lacks the *Cdx1-Cre* transgene. F, fibula; T, tibia. Scale bar, 500 *µ*m. (**G** and **G′**) Cross-sectional magnetic resonance images of P70 *Cdx1-Cre;Fz3*^*CKO/+*^ and *Cdx1-Cre;Fz3*^*CKO/−*^ hindlimbs show nearly complete degeneration and fibrosis of the anterior compartment musculature in the *Cdx1-Cre;Fz3*^*CKO/−*^ distal hindlimb. The anterior muscle compartment is delimited by a red border. The large and small dark territories are the tibia and fibula, respectively. (**H**--**J′**) NF immunostaining of whole-mount hindlimbs from E13.5 *Fz3*^*+/−*^*;Ret*^*+/−*^, *Fz3*^*−/−*^*;Ret*^*+/−*^, and *Ret*^*−/−*^ embryos. Boxed regions in (**H**--**J**) are enlarged in (**H′**--**J′**). In (**H**--**J**), white arrows and arrowheads indicate the dorsal nerve. (**H′**--**J′**) arrow and arrowhead colors: magenta indicates the dorsal nerve diameter proximal and white indicates the dorsal nerve diameter distal to the point where axons stall in *Fz3*^*−/−*^ limbs (asterisks). Depth is color coded as in [Figure 4B--F′](#fig4){ref-type="fig"}. Scale bars: (**J**), 500 *µ*m; (**J′**), 100 *µ*m. (**L**) Comparison of spinal motor axon growth and guidance defects in different knockout lines. In *Fz3*^*−/−*^ embryos, many dorsal motor axons fail to grow beyond a proximal branch point, whereas in *EphA4*^*−/−*^, *Gdnf*^*−/−*^, and *Ret*^*−/−*^ embryos, dorsal axons are misrouted to the ventral limb.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.016](10.7554/eLife.01482.016)10.7554/eLife.01482.017Figure 7---figure supplement 1.Comparison of dorsal nerve anatomy in forelimbs with various combinations of *Fz3* and *Ret* loss-of-function alleles.(**A**--**C′**) NF immunostaining on whole-mount forelimbs from E13.5 *Fz3*^*+/−*^*;Ret*^*+/−*^ (**A**), *Ret*^*−/−*^ (**B**), and *Fz3*^*−/−*^*;Ret*^*+/−*^ (**C**) embryos, with depth coded by color as in [Figure 4B](#fig4){ref-type="fig"}. (**A′**--**C′**) are a magnified view of the boxed regions in (**A**--**C**). Scale bars: (**C**), 500 *µ*m; (**C′**), 100 *µ*m.**DOI:** [http://dx.doi.org/10.7554/eLife.01482.017](10.7554/eLife.01482.017)

*Cdx1-Cre;Fz3*^*CKO/−*^ mice ambulate primarily with their forelimbs, which appear to be grossly normal, suggesting that the moderate thinning of the dorsal nerve in the forelimb does not seriously compromise innervation of the musculature. In cross sections of distal hind legs in *Hb9-EGFP*;*Fz3*^*−/−*^ embryos at E15.5, we observed a selective loss of motor innervation of the muscles of the anterior compartment (tibialis anterior, extensor hallucis longus, and extensor digitorum longus muscles) by the deep peroneal nerve ([Figure 7F,F′](#fig7){ref-type="fig"}), and in adult *Cdx1-Cre;Fz3*^*CKO/−*^ mice this same group of muscles is selectively and completely atrophied as determined by magnetic resonance imaging ([Figure 7G,G′](#fig7){ref-type="fig"}).

The severe plantar flexion of *Fz3*^*−/−*^ and *Cdx1-Cre;Fz3*^*CKO/−*^ hindfeet is readily understood from the anatomy of the limb musculature and its innervation ([@bib23]). The dorsal muscles in the embryonic limb become extensors and abductors, which are innervated by the peroneal nerve, while the ventral muscles become flexors and adductors, which are innervated by the tibial nerve. After the developing hindlimb undergoes a 90-degree rotation---which rotates the plantar surface of the foot away from the midline---the dorsal limb muscles face anteriorly and ventral limb muscles face posteriorly. Failure of dorsal nerve development affects muscles in the anterior compartment, which dorsiflex the foot. As a result, the normal balance between antagonistic flexor and extensor muscle groups is lost, and the action of the unopposed extensors leads to extreme plantar flexion of the foot.

Comparison of innervation defects in *Fz3*^*−/−*^ and *Ret*^*−/−*^ limbs {#s2-8}
------------------------------------------------------------------------

As noted in the Introduction, defects in motor axon guidance in the dorsal limb have been described in *EphA4*^*−/−*^, *Gdnf*^*−/−*^, and *Ret*^*−/−*^ embryos, and in each case dorsal motor axons are misrouted to the ventral limb. To compare one example of this class of mutants side-by-side with *Fz3*^*−/−*^ and to examine the possibility of a genetic interaction between the Fz3 and the GDNF/Ret signaling pathways, we examined limb innervation phenotypes in *Ret*^*−/−*^, *Fz3*^*+/−*^*;Ret*^*+/−*^, and *Fz3*^*−/−*^;*Ret*^*+/−*^ embryos ([Figure 7H--J′](#fig7){ref-type="fig"}). This analysis provides no evidence for a genetic interaction between *Fz3* and *Ret*, as *Fz3*^*+/−*^*;Ret*^*+/−*^ hindlimb innervation is indistinguishable from *WT*, and *Fz3*^*−/−*^*;Ret*^*+/−*^ hindlimb innervation is indistinguishable from *Fz3*^*−/−*^ (compare [Figures 4B--F′ and 7H--J′](#fig4 fig7){ref-type="fig"}, [Figure 4---figure supplements 1 and 2](#fig4s2){ref-type="fig"}, and [Figure 7---figure supplement 1A--C′](#fig7s1){ref-type="fig"}). Our analysis of *Ret*^*−/−*^ fore- and hindlimb innervation fully confirms previous descriptions ([@bib38]) and shows that in *Ret*^*−/−*^ hindlimbs the dorsal nerve is thinned to a similar extent both proximal and distal to the point at which *Fz3*^*−/−*^ dorsal motor axons stall (asterisks in [Figure 7H′--J′](#fig7){ref-type="fig"}) and the ventral nerve is thicker than its counterpart in *WT* littermates, consistent with a rerouting of dorsal motor axons to the ventral nerve. These experiments confirm that the *Fz3*^*−/−*^ dorsal motor axon phenotype is anatomically distinct from the phenotypes described in *EphA4*^*−/−*^, *Gdnf*^*−/−*^, and *Ret*^*−/−*^ limbs ([Figure 7K](#fig7){ref-type="fig"}).

Discussion {#s3}
==========

The experiments reported here establish a role for Frizzled signaling in the growth of a subset of cranial and spinal motor axons. In the absence of Fz3, innervation is decreased or entirely missing from the musculature of the tongue, snout, diaphragm, and the dorsal (which will later become the anterior) compartment of the lower hindlimbs. In the limb, the *Fz3*^*−/−*^ phenotype is distinct from several previously described axon guidance phenotypes. *Fz3*^*−/−*^ LMC~L~ axons, which are normally destined to innervate the dorsal limb musculature, stall abruptly within the plexus and do not adopt a default trajectory as observed in embryos with loss of EphrinA/EphA4, Sema3F/Npn2, and GDNF/Ret signaling. The loss of Fz3 also leads to the precocious apoptotic death of affected cranial and spinal motor neurons, a phenotype not observed in embryos with defective EphrinA/EphA4 and GDNF/Ret signaling ([@bib26]; [@bib38]). To the best of our knowledge, the only previously reported mammalian axon guidance phenotype that might resemble the *Fz3*^*−/−*^ phenotype to some extent is that seen in the absence of *Linx*, a transmembrane protein of the LIG family that has been implicated as a cofactor in receptor tyrosine kinase signaling ([@bib43]; [@bib44]).

These observations raise a number of fascinating questions. Since Fz3 is widely expressed in the developing CNS, why are the motor neuron phenotypes restricted to a subset of motor axons? Are other Frizzled receptors playing analogous or redundant roles in other motor axons? Do signaling molecules produced by target tissues---for example, Wnts---relay positional information to the axon via PCP proteins? Is there an interaction between PCP signaling and other axon guidance systems? By what mechanism is information from PCP proteins at the plasma membrane communicated to the axon's cytoskeleton to control axonal growth? What is the survival signal that keeps *WT* LMC~L~ motor neurons alive at E11-E13, but fails to act on *Fz3*^*−/−*^ LMC~L~ motor neurons?

Cre lines that permit postnatal survival by localizing nervous system defects to caudal territories {#s3-1}
---------------------------------------------------------------------------------------------------

Of technical interest is our use of Cre-mediated recombination in the caudal ∼80% of the embryo as a strategy for studying genes that are required more rostrally for survival (e.g., genes required for brain development). The *Cdx1-Cre* transgene used here recombines *LoxP* targets at ∼100% efficiency by ∼E8 in all solid tissues caudal to the upper thorax ([@bib27]). A *Cdx2-Cre* transgene produces a similar pattern of recombination except that the most rostral extent of recombination is located roughly at the umbilicus ([@bib29]). Thus, mice harboring a conditional allele that impairs cardiac or pulmonary function would likely be spared if the allele was recombined with the *Cdx2-Cre* transgene. These two *Cre* lines should be generally useful for studying spinal cord, DRG, and peripheral nerve phenotypes in postnatal mice harboring conditional alleles in a wide variety of genes.

Fz3 and neural crest migration {#s3-2}
------------------------------

NC cell migration is one of the most dramatic migration processes in vertebrate development. At mid-gestation, NC cells delaminate from the dorsal neuro-ectoderm to populate skin (melanocytes), viscera (sympathetic, parasympathetic, and enteric neurons), DRGs (somatosensory neurons), the adrenal medulla, and a variety of mesenchymal structures in the head ([@bib18]). Genetic defects in melanocyte and enterocyte migration have been extensively studied in mice and humans where they produce easily recognized phenotypes, such as skin depigmentation and aganglionic colon (Waardenberg disease and Hirschprung disease; [@bib20]). Migration of enteric neurons requires endothelin3/endothelin receptor B and GDNF/Ret signaling. In various experimental contexts, cadherins, integrins, and Eph/Ephrins have also been found to influence NC migration ([@bib47]). Our observation that Fz3 promotes the initial step in NC migration represents a new connection between PCP signaling and NC migration. *Fz3*^*−/−*^ embryos also exhibit subtle defects in the migration of monoaminergic neurons ([@bib19]) and more severe defects in the migration of VII^th^ cranial nerve neurons ([@bib55]), but, in general, neuronal migration defects are not a prominent feature of the *Fz3*^*−/−*^ phenotype.

At E11.5, a time when only a small fraction of cells within the DRG are dying, the non-migratory NC-derived neuron clusters in *Fz3*^*−/−*^ embryos show a high density of apoptotic cells. Whether cell death is triggered directly by the failure of cell migration or is a secondary consequence of migratory failure---for example, as a result of incorrect routing of axons produced by neurons within the clusters---it represents an impressive demonstration of the rapidity and efficiency with which the developing nervous system recognizes and eliminates errors. In this respect, it bears a conceptual, and possibly a mechanistic, resemblance to the rapid elimination of the *Fz3*^*−/−*^ LMC~L~ neurons with stalled axons.

Implications of axon stalling and rapid motor neuron death in *Fz3*^*−/−*^ embryos {#s3-3}
----------------------------------------------------------------------------------

Axon stalling has been observed in diverse systems either as part of the normal pattern of axon outgrowth or as a phenotypic consequence of mutation. In the first category are the ∼1 day waiting period during which sensory and motor axons stall at the base of the developing chick hindlimb ([@bib70]) and the alternating phases of stalling and growth that characterize motor axon path-finding in *C. elegans* ([@bib36]). In the second category are the stalling phenotypes observed among sensory neurons in *Drosophila* embryos carrying mutations in the Neuroglian gene (*Nrg*; [@bib46]) or in the gene coding for the PCP protein Flamingo (*Fmi*; the *Drosophila* orthologue of the mammalian *Celsr* genes; [@bib67]), among spinal motor axons in zebrafish carrying collagen XIX mutations ([@bib7]; [@bib28]), and among post-crossing commissural axons in the spinal cord in mouse *Robo1* mutants ([@bib34]). Although the mechanistic link between extra-cellular signals or adhesive interactions and axon stalling has not been defined for any of these examples, a potentially unifying framework has emerged from studies of the relationship between calcium transients and growth cone motility. Within growth cones, calcium release and motility are inversely correlated, with rapidly moving growth cones showing the lowest frequency calcium transients and stalled or retracting growth cones showing the highest frequency calcium transients ([@bib21]). In the present study, the loss of *Fz3* blocks growth but does not alter path-finding among dorsal limb motor axons, and therefore presents as a pure stalling phenotype. However, we note that the conceptualization of axon growth and path-finding as distinct behaviors may be simplistic, since the two attributes could be related mechanistically if axon growth is dependent on the same signals that guide the path-finding process.

During normal embryonic development, motor axons compete for limited quantities of survival factors produced by their skeletal muscle targets, with the result that in the prenatal mouse \>50% of motor neurons die beginning at E13.5 ([@bib51]; [@bib62]). Among *Fz3*^*−/−*^ LMC~L~ neurons, a wave of cell death begins at E11.5, well before LMC~L~ axons have reached their final muscle targets, and 2 days before the normal wave of motor neuron cell death ([@bib35]; [@bib52]). The precocious motor neuron death in *Fz3*^*−/−*^ embryos is unlikely to reflect survival factors derived from skeletal muscle because even in the complete absence of skeletal myoblasts, myofibers, and muscle---a phenotype produced in *Myf5*^*−/−*^;*MyoD*^*−/−*^ embryos---motor neuron cell death does not occur prior to E13.5 ([@bib35]). Taken together, the *Fz3*^*−/−*^ and *Myf5*^*−/−*^;*MyoD*^*−/−*^ phenotypes imply that motor neuron survival between E11.5 and E13.5 is an active process and is independent of the motor axon's ultimate target. One class of models that could account for the precocious motor neuron death in *Fz3*^*−/−*^ embryos invokes the existence of neuronal survival factors produced by intermediate targets along an axon's trajectory, as suggested by in vitro co-culture experiments with spinal cord commissural axons and floor plate tissue ([@bib71]). The *Fz3*^*−/−*^ experiments reported here provide in vivo evidence for this model, and suggest that the hypothesized survival factor(s) reside distal to the plexus but proximal to the developing muscle target. We note that alternative models are also consistent with the data, including, for example, the possibility of anti-survival signals at the point of *Fz3*^*−/−*^ axon stalling.

While the precocious cell death of *Fz3*^*−/−*^ motor neurons can be rescued by eliminating *Bax*, the axon stalling phenotype remains unchanged. This observation is consistent with a model in which a defect in Fz3-dependent axonal growth induces apoptotic cell death, and it argues against an alternate model in which Fz3 functions in some other process to maintain cell viability, with defective axonal growth representing a secondary effect of the neuron's impending demise. A corollary to this argument is that controlling axonal growth may be the only function of Fz3 in motor neurons.

Planar cell polarity components in axon growth and guidance {#s3-4}
-----------------------------------------------------------

In earlier work, *Fz3*^*−/−*^, and *Celsr3*^*−/−*^ forebrains were found to have essentially identical defects in multiple axon tracts ([@bib72],[@bib74]; [@bib68]), and in *Fz3*^*−/−*^, *Celsr3*^*−/−*^, and *Vangl2*^*Lp/Lp*^ spinal cords the commissural axons of dorsal horn sensory neurons were found to exhibit the same rostral turning defect ([@bib42]; [@bib68]; [@bib54]; [@bib63]). The present work strongly suggests that, in the context of motor axon growth and guidance, Fz3 and one or more Celsr family members are also likely to act together in the same pathway.

In a wide variety of epithelia, planar cell polarity proteins are arranged in asymmetric cell surface complexes ([@bib64]; [@bib22]). At the junctions between adjacent cells, the large cadherin-containing Stan/Fmi/Celsr proteins accumulate at the plasma membranes of both cells and are presumed to form homophilic adhesive interactions. By contrast, Frizzled proteins accumulate at the plasma membrane of one cell and Vang/Stan/Vangl proteins accumulate at the plasma membrane of the opposing cell. The general assumption in the field is that the asymmetric distribution of Frizzled and Vangl proteins is a prerequisite for transmitting polarity information within the plane of the epithelium ([@bib22]; [@bib53]).

The current conceptual framework appears well suited to explain signal transmission via cell surface complexes of PCP proteins within relatively stable epithelial monolayers. This framework can also accommodate more dynamic situations in which epithelial cells divide or exchange partners on time scales of minutes to tens of minutes, as seen, for example, during convergent extension movements. Although the dynamics of PCP protein complexes remains largely undefined, one study of their trafficking during the cell cycle shows that these complexes can dis-assemble and reassemble on a time scale of tens of minutes ([@bib16]). The axonal development phenotypes produced by loss of Fz3 or Celsr3 raise an apparent paradox if we imagine that Fz3 and Celsr3 sense and integrate environmental information to control axonal growth by forming the same type of cell-surface complexes in growth cones---and, in particular, in growth cone filopodia---as they do in epithelia. Such a scenario would imply that the time scales of assembly and dis-assembly of PCP protein complexes and engagement with and disengagement from partners in the environment would need to occur on the time scale of growth cone dynamics, that is seconds to tens of seconds ([@bib60]).

At present, the subcellular location of endogenous PCP proteins in developing neurons has not been determined. However, experiments with dissociated commissural neurons that express transfected Fz3 or Vangl2 tagged with fluorescent reporters show that Fz3 is enriched in intracellular vesicles and Vangl2 is localized throughout the growth cone plasma membrane with the highest concentration in filopodia ([@bib63]). While current models of PCP protein action in growth cones are necessarily speculative, the axon growth phenotypes suggest that the signaling repertoire of PCP proteins is more diverse than would be predicted from considerations based only on epithelia. These and other Frizzled and Celsr phenotypes suggest that 'tissue polarity', the original name for the signals sent and received by this pathway, might be more apt than the epithelium-centric name 'planar cell polarity'.

Materials and methods {#s4}
=====================

Mouse lines {#s4-1}
-----------

The *Fz3*^*CKO*^ allele was generated by homologous recombination in mouse embryonic stem (ES) cells using standard techniques. The targeting construct contained exon 3 with 3.4 kb of 5′ and 6.4 kb of 3′ flanking intronic sequences. An HA epitope was inserted in the linker region that connects the cysteine-rich ligand-binding domain and the first transmembrane domain (a region encoded in the third exon). A *neomycin phosphotransferase* (*neo*) selection marker with flanking *Frt* sites was inserted 3′ of exon 3, and *LoxP* sites were placed 5′ of exon 3 and 3′ of *neo* ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). The targeting construct was electroporated into R1 mouse ES cells, and colonies were grown in medium containing G418 and ganclovir. Colonies were screened by Southern blot hybridization, and positive clones were injected into C57BL/6 blastocysts to generate chimeric founders. Germline transmission was confirmed by Southern blot hybridization and PCR. The *neo* cassette was removed by crossing to germline *Flp* mice ([@bib56]).

The following mouse lines were also used: *Fz3*^*−/−*^ ([@bib72]), *Bax*^*−/−*^ ([@bib37]), *R26iAP* ([@bib4]), *Hb9-EGFP* ([@bib76]), *ChAT-IRES-Cre* (JAX \#006410; The Jackson Laboratory, Bar Harbor, ME), *Olig2*^*Cre*^ (i.e., a Cre knock-in at the *Olig2* locus; [@bib15]), *Wnt1-Cre* ([@bib13]), and *Cdx1-Cre* ([@bib27]).

Alkaline phosphatase (AP) histochemistry {#s4-2}
----------------------------------------

Throughout this work, the first day after finding a copulation plug was counted as embryonic day 0.5 (E0.5). For the analysis of E18.5 embryos, skinned heads were immersion fixed in 4% paraformaldehyde (PFA) at 4°C overnight with gentle shaking, washed three times in phosphate buffered saline (PBS), pH 7.4, and then decalcified in 50 mM EDTA, pH 7.0 at 4°C for 1 week. Heads were embedded in 3% low melting point agarose in PBS and sectioned at 200 *µ*m on a vibratome. AP histochemistry was performed essentially as previously described ([@bib5]). Sections were washed twice in PBS with 2 mM MgCl~2~, heated in a water bath at 69°C for 90 min to inactivate endogenous AP activity, and then equilibrated in AP staining buffer (0.1 M Tris, 0.1 M NaCl, 50 mM MgCl~2~, pH 9.5). AP histochemistry were carried out in AP staining buffer containing 0.34 *µ*g/ml 4-nitro blue tetrazolium chloride (NBT) and 0.175 *µ*g/ml 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) (Roche Applied Science; Indianapolis, IN), for 1 hr to overnight at room temperature with gentle horizontal rotation. Before imaging, sections were dehydrated through an ethanol series and then cleared with BBBA \[2:1 benzyl benzoate (BB)/benzyl alcohol (BA)\] (Sigma-Aldrich; St. Louis, MO).

Immunohistochemistry {#s4-3}
--------------------

The following primary antibodies were used: mouse monoclonal anti-Neurofilament (165 kDa) (2H3; Developmental Studies Hybridoma Bank \[DSHB\]; Iowa City, IA), mouse monoclonal anti-Islet1 (39.3F7; DSHB), mouse monoclonal anti-Islet1/2 (39.4D5; DSHB), rabbit anti-Brn3a (MAB1585; Millipore; Billerica, MA), rabbit anti-Caspase3 (9661; Cell Signaling Technology; Boston, MA), rabbit anti-Foxp1 (ab16645; Abcam; Cambridge, MA), rabbit anti-GFP (A11122; Invitrogen; Grand Island, NY), goat anti-Sox10 (SC-17342; Santa Cruz Biotechnology; Dallas, TX), rabbit anti-Islet1, anti-Islet2, and anti-Islet1/2 (gifts of Dr Tom Jessell and Susan Morton; Columbia University). Secondary antibodies were Alexa Fluor 488, Alexa Fluor 594, or Alexa Fluor 647 conjugated, donkey anti-goat, goat anti-mouse, or goat anti-rabbit IgG antibodies (Invitrogen). Alexa Fluor 647 α-Bungarotoxin (B35450; Invitrogen) was used to label acetylcholine receptors.

Immunostaining was performed on (1) embryos that were either (a) immersion fixed in 4% PFA at 4°C for 1 hr, washed three times in cold PBS, equilibrated in PBS containing 30% sucrose, embedded in optimal cutting temperature (OCT) compound (Sakura Finetek; Torrance, CA), frozen, and sectioned at 14 *µ*m on a cryostat; or (b) immersion fixed in 4% PFA at 4°C overnight, washed three times in cold PBS, embedded in 3% low melting point agarose, and sectioned at 100 *µ*m or 700 *µ*m on a vibratome; and (2) whole-mount embryos and limbs that were immersion fixed in 4% PFA at 4°C for 2 hr and washed three times in cold PBS.

For immunostaining of cryosections, sections were rinsed in PBS three times, blocked in PBST (PBS with 0.3% Triton X-100) containing 5% normal goat or donkey serum (NGS or NDS) at room temperature for 1 hr, and incubated with primary antibodies in PBST containing 5% NGS or NDS at 4°C overnight. Sections were then washed three times in PBS, and incubated with secondary antibodies in PBST containing 5% NGS or NDS at room temperature for 1 hr. Finally sections were washed three times in PBS, and slides were mounted with Fluoromount-G (Southern Biotech; Birmingham, AL).

For immunostaining of 100 *µ*m-thick vibratome sections, sections were blocked in PBST containing 5% NGS or NDS at room temperature for 1 hr, and incubated with primary antibodies in PBST containing 5% NGS or NDS at 4°C overnight. Sections were then washed five times in PBST, and incubated with secondary antibodies in PBST containing 5% NGS or NDS at 4°C overnight. Finally sections were washed five times in PBST, and sections were mounted on slides with Fluoromount-G.

For immunostaining of 700 *µ*m-thick vibratome sections or whole-mount embryos and limbs, samples were first incubated in Dent's Bleach (10% H~2~O~2~, 13.3% dimethyl sulfoxide \[DMSO\], 53.3% methanol) at 4°C for 24 hr, washed in methanol five times, and fixed in Dent's Fix (20% DMSO, 80% methanol) at 4°C overnight. Samples were washed in PBS three times, incubated with primary antibody in blocking solution (20% DMSO, 75% PBST, 5% NGS, 0.025% sodium azide) at room temperature for 5 days to one week with gentle end-over-end rotation, and then washed five times in PBST. Samples were incubated with secondary antibody in blocking solution at room temperature for 2 days with gentle end-over-end rotation and then washed five times in PBST. Finally samples were dehydrated in 50% methanol/PBS and methanol, and cleared in BBBA. Immunofluorescent signals are stable for \>1 week at room temperature in BBBA, and stained tissue samples can be stored for \>3 months in methanol at 4°C and returned to BBBA with no discernable loss of image quality or signal strength.

Microscopy and image analysis {#s4-4}
-----------------------------

Samples processed for AP histochemistry were imaged using a Zeiss Stemi V11 microscope with a color Axiocam CCD in combination with Openlab software. Immunostained samples were imaged using a Zeiss LSM700 confocal microscope with Zen software. Images of vibratome-cut thick samples or whole-mounts were acquired with a 10X air objective at 10 *µ*m intervals in the Z dimension, and the entire Z stack was either collapsed using a maximum intensity projection or color-coded based on depth. Custom built metal and plexiglass embryo holders consisted of a shallow triangular trough (sides: 2 cm × 2 cm × 1 cm; and depths: 1, 2, 3, or 4 mm) into which the BBBA-cleared embryo could be positioned. The trough was then filled with BBBA, and coverslipped. Imaging a BBBA-cleared E11.5 embryo with a 10X objective, a single fluorescent channel, and 10 *µ*m Z-axis steps generates a ∼1.5 Gb file, which can be acquired in ∼3 hr on a Zeiss LSM700 confocal microscope.

Quantification of motor neurons, measurement of nerve diameter, and statistical analysis {#s4-5}
----------------------------------------------------------------------------------------

The number of motor neurons on each section was manually quantified in ImageJ. To measure the thickness of nerves innervating the limb, lines perpendicular to and extending across the nerve were drawn at designated sites in Adobe Illustrator and the length of these lines was determined. Statistical comparisons (student's *t*-test) were performed using GraphPad Prism 5.

Magnetic resonance imaging (MRI) of mouse limbs {#s4-6}
-----------------------------------------------

P70 *Cdx1-Cre;Fz3*^*CKO/−*^ and control mice from the same litter were fixed by cardiac perfusion. Hindlimbs were imaged by MRI as previously described ([@bib78]).
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Thank you for sending your work entitled "*Frizzled3* controls axonal development in distinct populations of cranial and spinal motor neurons" for consideration at *eLife*. Your article has been favorably evaluated by a Senior editor and 4 reviewers, one of whom is a member of our Board of Reviewing Editors.

The following individuals responsible for the peer review of your submission have agreed to reveal their identity: Robb Krumlauf served as the Reviewing editor and Yimin Zou was one of the peer reviewers.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

The consensus opinion of the reviewers is that they are enthusiastic about this paper and would like to see a revised version published in *eLife*. It presents an extensive description of novel motor neuron and peripheral nervous system defects in *Fz3* mutants. The genetic experiments are elegant, the experiments thoughtful, and the data striking. There are two primary concerns that need to be addressed and they are summarized below.

1\) The first is that the density of the results and the extensive survey of phenotypes while impressive make it challenging for the reader to take away the key findings from the study. The volume of data is at times overwhelming, which makes it hard to work through and appreciate the subtleties of the many observations. Thought needs to be given to finding a coherent way to summarize the key results in an effective way for the reader in the Discussion. Perhaps the authors could emphasize more clearly the role of Frizzled3 in motor neuron target innervation and survival in the periphery, which is indeed the main finding being reported. Peripheral growth and innervation is a very important issue in the context of peripheral nerve injury and peripheral neuropathy. One suggestion is to simplify the data. This paper is filled with detailed results that make it harder for readers for grasp the main findings. Since the motor axon defects are mostly on the dorsal limb, the authors could focus on showing these dorsal axons. Showing other axons that do not display defects makes it very convincing that only a selected group of axons are affected but these might unnecessarily overwhelm the reader. The authors could simply show one to two images of these as "controls" and then clearly illustrate the main phenotype. This will sharpen the focus on the key results.

2\) The second general issue relates to postulated mechanisms or level of mechanistic insight underlying the phenotypes. Because of the effort made in describing so many diverse phenotypes the study does not go into much mechanistic characterization that could help to understand how Fz3 acts, why specific motor neuron subtypes are affected and/or a molecular explanation for the axon stalling. As a consequence, the paper presents interpretations or speculation on mechanisms associated with phenotypes, which may have alternative explanations.

For example, the difference between axon outgrowth and guidance needs to be made clearer. The point about outgrowth is emphasized throughout the paper but other interpretations are also possible. The authors show that axons stall and then die but it is premature to conclude based on the limb phenotype alone that axons die because they don\'t reach an intermediate target. The statement that neurons with long-range axons are programmed to die unless their axons arrive at intermediate targets on schedule is not really supported by the data. How can a role for intermediate targets be distinguished from a role of the final target in survival? It is unclear whether the *Fz3* mutant motor neurons die because of an intrinsic neuronal defect, a defect in the cell\'s ability to transport survival signals from intermediate or distal targets, or the failure of LMCl axons to contact distal targets that supply trophic support. Integrating these possibilities into the Discussion and less speculation on the mechanism would seem appropriate in the absence of supporting data.

The reviewers are hesitant to request additional experimental detail to complement an already dense study. However, if the report included explant assays it might be possible to determine whether LMCl axons lack an intrinsic ability to extend long axons versus a more direct role of *Fz3* in axon targeting.
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Author response

*There are two primary concerns that need to be addressed and they are summarized below*.

*1) The first is that the density of the results and the extensive survey of phenotypes while impressive make it challenging for the reader to take away the key findings from the study. The volume of data is at times overwhelming, which makes it hard to work through and appreciate the subtleties of the many observations. Thought needs to be given to finding a coherent way to summarize the key results in an effective way for the reader in the Discussion. Perhaps the authors could emphasize more clearly the role of Frizzled3 in motor neuron target innervation and survival in the periphery, which is indeed the main finding being reported. Peripheral growth and innervation is a very important issue in the context of peripheral nerve injury and peripheral neuropathy. One suggestion is to simplify the data. This paper is filled with detailed results that make it harder for readers for grasp the main findings. Since the motor axon defects are mostly on the dorsal limb, the authors could focus on showing these dorsal axons. Showing other axons that do not display defects makes it very convincing that only a selected group of axons are affected but these might unnecessarily overwhelm the reader. The authors could simply show one to two images of these as "controls" and then clearly illustrate the main phenotype. This will sharpen the focus on the key results*.

To decrease the amount of data in the regular figures and focus the presentation, we have taken roughly 50% of the panels from [Figure 2](#fig2){ref-type="fig"} (panels Ca-g', Da-d', E, E', and I-K'; 30 panels total) and transferred them to a figure supplement. This moves most of the data regarding cranial nerves and cranial nerve nuclei to the figure supplements. We have also changed panel B' of [Figure 1](#fig1){ref-type="fig"}, which, in the original version, showed a potentially confusing superposition of two nerves from different Z-planes that created the illusion that the two might be connected. Finally, we have focused the writing in the Results section to ensure that each sub-section has a clear statement of the experimental question, the experimental results, and the interpretation of those results.

*2) The second general issue relates to postulated mechanisms or level of mechanistic insight underlying the phenotypes. Because of the effort made in describing so many diverse phenotypes the study does not go into much mechanistic characterization that could help to understand how Fz3 acts, why specific motor neuron subtypes are affected and/or a molecular explanation for the axon stalling. As a consequence, the paper presents interpretations or speculation on mechanisms associated with phenotypes, which may have alternative explanations*.

*For example, the difference between axon outgrowth and guidance needs to be made clearer. The point about outgrowth is emphasized throughout the paper but other interpretations are also possible. The authors show that axons stall and then die but it is premature to conclude based on the limb phenotype alone that axons die because they don\'t reach an intermediate target. The statement that neurons with long-range axons are programmed to die unless their axons arrive at intermediate targets on schedule is not really supported by the data. How can a role for intermediate targets be distinguished from a role of the final target in survival? It is unclear whether the* Fz3 *mutant motor neurons die because of an intrinsic neuronal defect, a defect in the cell\'s ability to transport survival signals from intermediate or distal targets, or the failure of LMCl axons to contact distal targets that supply trophic support. Integrating these possibilities into the Discussion and less speculation on the mechanism would seem appropriate in the absence of supporting data*.

We have gone through the text to clarify the writing so that there is a clear distinction between (a) the experimental outcomes and (b) the hypotheses regarding the possible mechanisms underlying those outcomes. In the Discussion, we have also clarified the distinction between axon outgrowth and guidance, although we note that at a mechanistic level these seemingly distinct characteristics may be interconnected, since a failure to grow at a particular point (the phenotype that we observe among *Fz3*^*-/-*^ motor axons that were destined to innervate the dorsal hind limb) may reflect an underlying inability to choose a correct path at that juncture.

We agree with the editor's comment that "it is premature to conclude based on the limb phenotype alone that axons die because they don\'t reach an intermediate target". However, we would still like to propose this as the leading hypothesis to explain the data. Regarding the editor's next question and sentence: "How can a role for intermediate targets be distinguished from a role of the final target in survival? It is unclear whether the Fz3 mutant motor neurons die because of an intrinsic neuronal defect, a defect in the cell\'s ability to transport survival signals from intermediate or distal targets, or the failure of LMCl axons to contact distal targets that supply trophic support." This indicates that we have not clearly explained the argument. Our logic is as follows: (1) in the *Fz3*^*-/-*^ spinal cord, the axons of motor neurons that innervate the dorsal limb stall at the base of the limb at E11.5; (2) the same motor neuron population (and only that population) undergoes massive cell death at the same age (E11.5); (3) in WT embryos, motor axons reach their final targets 2 days later (E13.5), at which time ∼50% of motor neurons start to undergo developmental cell death; and (4), as described in the Discussion, the genetic elimination of all muscle cells (the distal/final target of motor neurons) in *Myf5*^*-/-*^;*MyoD*^*-/-*^ embryos (Kablar and Rudnycki, 1999) produces massive motor neuron death, but this wave of cell death only begins at the normal time, E13.5, i.e., when the motor axons arrive at the place where the muscle targets should be. Points (3) and (4) imply that the time window when trophic support from distal/final muscle targets becomes required for motor neuron survival begins at E13.5, as judged by the timing of motor neuron death in the absence of that support. Points (1) and (2) demonstrate that in *Fz3*^*-/-*^ embryos, axon stalling and precocious motor neuron death occur two days prior to the arrival of WT motor axons at their final targets and two days prior to the time when trophic support from distal/final targets is needed to maintain WT motor neuron viability. Putting together points (1)-(4), we conclude that motor neuron death in *Fz3*^*-/-*^ embryos in not due to trophic effects from the final distal/targets. Furthermore, the coincidence in time between axon stalling and motor neuron death in the same population of motor neurons in *Fz3*^*-/-*^ embryos suggests that the two events may be mechanistically coupled, although a skeptic could argue that loss of *Fz3* produces axon stalling and cell death in the same subset of neurons at the same time via two unrelated processes.

We think that the newly included paragraph in the Discussion section that is devoted to this issue clearly lays out this logic. Here and elsewhere we have been careful to indicate that the intermediate target hypothesis is just a hypothesis, not an established fact. In the Abstract, we characterize the data as "providing in vivo evidence for the idea that developing neurons..." and in the Discussion we characterize the intermediate target hypothesis as a "model" and we write that the data "provide in vivo evidence for this model", and that "alternative models are also consistent with the data".

*The reviewers are hesitant to request additional experimental detail to complement an already dense study. However, if the report included explant assays it might be possible to determine whether LMCl axons lack an intrinsic ability to extend long axons versus a more direct role of* Fz3 *in axon targeting*.

We agree that additional experimental data could add substantially to this work -- in particular, the identification of putative growth and/or guidance molecules that act through Fz3, or putative intermediate target-derived trophic factors. However, such an undertaking would constitute a major and independent body of work. In vitro culture experiments that merely recapitulate the in vivo behavior of *Fz3*^*-/-*^ axons without leading to real mechanistic insights would add only modestly to the present picture. As the work now stands, we believe it constitutes a comprehensive in vivo body of experimental data with several novel and well-documented biological findings, and therefore it makes sense to publish the body of work in essentially its present form. We have added a paragraph to the Discussion section to provide more background on axon stalling and to address the growth vs guidance issue.

"Axon stalling has been observed in diverse systems either as part of the normal pattern of axon outgrowth or as a phenotypic consequence of mutations..."
